SPARTA BIODISCOVERY

sparta-biodiscovery-logo

SPARTA Biodiscovery Facilitating nanoformulations for upcoming therapies

#SimilarOrganizations #Financial #Website #More

SPARTA BIODISCOVERY

Social Links:

Industry:
Biotechnology Nanotechnology Therapeutics

Founded:
2022-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.spartabiodiscovery.com

Status:
Active

Email Addresses:
[email protected]

Total Funding:
3.5 M GBP

Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset COVID-19


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

vintabio-logo

VintaBio

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

Investors List

sartorius_image

Sartorius

Sartorius investment in Seed Round - SPARTA Biodiscovery

Official Site Inspections

http://www.spartabiodiscovery.com

  • Host name: plesk.smartastudio.com
  • IP address: 77.68.116.37
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "SPARTA Biodiscovery"

About » SPARTA Biodiscovery

The SPARTA ® technology, offered exclusively by SPARTA Biodiscovery, fulfils this need through its ability to chemically characterise the individual particles in nanomedicines to ensure each …See details»

SPARTA Biodiscovery - Crunchbase Company Profile

SPARTA Biodiscovery may be growing as it has secured up to £3.5 million in funding to speed up its commercial roll-out. This financial injection suggests an expansion of operations and an increase in the company's ability to invest in …See details»

SPARTA Biodiscovery Company Profile 2024: Valuation, …

SPARTA Biodiscovery General Information Description. Provider of nanoparticle analytical testing services catering to the pharmaceutical and biotechnology industry. The company offers analytical testing of nanoparticle types used for …See details»

SPARTA Biodiscovery - The Org

SPARTA Biodiscovery is a brand-new spin-out company from Imperial College London developing and commercialising the SPARTA® technology. SPARTA® (Single Particle …See details»

SPARTA Biodiscovery - London, United Kingdom - bionity.com

Oct 2, 2023 spartabiodiscovery.com. Contact. Profile News. Contact. About SPARTA Biodiscovery. SPARTA Biodiscovery is a spin-out company from Imperial College London …See details»

Member profile: SPARTA Biodiscovery Limited | BIA

Scale Space White City, 58 Wood Lane, London, W12 7RZ, United KingdomSee details»

SPARTA Biodiscovery - Company Profile - Tracxn

Aug 31, 2024 SPARTA Biodiscovery - Enabling nanoformulations for next-generation therapeutics through cutting-edge benchtop technology.. Raised a total funding of $4.3M over …See details»

SPARTA Biodiscovery - LinkedIn

SPARTA Biodiscovery is a brand-new spin-out company from Imperial College London developing and commercialising the SPARTA® technology. SPARTA® (Single Particle …See details»

SPARTA Biodiscovery Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore SPARTA Biodiscovery Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

SPARTA BIODISCOVERY LIMITED overview - Find and update …

SPARTA BIODISCOVERY LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»

SPARTA Biodiscovery Ltd. - Drug pipelines, Patents, Clinical trials ...

3 days ago spartabiodiscovery.com. Last update 24 Dec 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. …See details»

Sparta Biodiscovery - Products, Competitors, Financials, Employees ...

Oct 4, 2023 spartabiodiscovery.com. Overview & Products; Financials; People; Founded Year 2022. Stage Seed | Alive. Total Raised $4.28M. Last Raised $4.28M | 9 mos ago. About …See details»

Contact - SPARTA Biodiscovery

SPARTA Biodiscovery Scale Space White City, 58 Wood Lane London W12 7RZ, United KingdomSee details»

New startup to help pharmaceutical companies develop …

Sep 26, 2022 BOOSTING NANOPARTICLE R&D - Imperial startup SPARTA Biodiscovery is offering technology to accelerate the development and production of nanoparticles used in …See details»

Technology - SPARTA Biodiscovery

The research behind SPARTA ®. We have published the core concepts behind SPARTA ® in the high-impact journal Nature Communications open-access available on the link here.. The …See details»

SPARTA Biodiscovery

SPARTA Biodiscovery Scale Space White City, 58 Wood Lane London W12 7RZ, United KingdomSee details»

Services » SPARTA Biodiscovery

Single particle automated Raman trapping analysis. SPARTA ® is compatible with most common nanoparticle types used for diagnostic and therapeutic purposes. We have extensive expertise …See details»

Early Access » SPARTA Biodiscovery

Early Access Program (EAP) The SPARTA® AGIS I is a unique benchtop instrument that measures the chemical composition of both carrier and cargo, label free at the single particle …See details»

Applications - SPARTA Biodiscovery

Applications. Discover the wide breadth of possibilities with SPARTA ®. SPARTA ® has been successfully applied in a range of publications in leading academic journals such as Nature …See details»

linkstock.net © 2022. All rights reserved